Our mission is to bridge the gap between patients and dermatologists and to drastically reduce waiting times for university hospital appointments, which currently exceed six months. HybridVITA leverages state-of-the-art technology to enhance interaction, diagnosis, and therapy for patients with chronic inflammatory skin diseases.

Through our mobile software application, which runs on any conventional smartphone, dermatologists can visually quantify and "feel" the blood flow and texture of skin lesions—all during a virtual ward round. This tech-supported approach enables early diagnostics, a simple method for triaging, and the faster initiation of necessary therapies.

HybridVITA is more than just an app. It is a solution designed to maintain care for patients with chronic inflammatory skin diseases even in exceptional situations. By using intelligent pre-aggregation of longitudinal data, we can distinguish severe disease progressions from mild ones, enabling better triaging. With HybridVITA, approximately 50% of direct patient contacts in dermatology practices and clinics could be avoided.

In a world where the demand for telemedicine applications is steadily growing, HybridVITA offers a secure and effective solution for patients who require high-quality medical care without compromising their health. Our AI-based app aims to significantly improve the physical and mental health of these patients while predicting and preventing severe disease flare-ups.